Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Editorial: The predictive bene...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Editorial: The predictive benefits of inflammatory markers in cancers of the liver

Editorial: The predictive benefits of inflammatory markers in cancers of the liver

Bibliographic Details
Main Authors: Gianluca Rompianesi, Domenico Tamburrino
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Oncology
Subjects:
liver cancer
inflammatory markers
hepatocellular carcinoma (HCC)
cholangiocarcinoma (CCA)
predictive ability
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1386388/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1386388/full

Similar Items

  • Studying of serum bile acids metabolomics as potential biomarkers for differentiation between hepatocellular carcinoma and cholangiocarcinoma
    by: Azza Mahmoud El Sheashaey, et al.
    Published: (2024-10-01)
  • Cellular Senescence in Liver Cancer: How Dying Cells Become “Zombie” Enemies
    by: Aurora Gazzillo, et al.
    Published: (2023-12-01)
  • Update on the Genetics of and Systemic Therapy Options for Combined Hepatocellular Cholangiocarcinoma
    by: Alexander A. Azizi, et al.
    Published: (2020-09-01)
  • Disparities in care and outcomes for primary liver cancer in England during 2008–2018: a cohort study of 8.52 million primary care population using the QResearch databaseResearch in context
    by: Weiqi Liao, et al.
    Published: (2023-05-01)
  • Diagnostic Performance of LI-RADS Version 2018 for Primary Liver Cancer in Patients With Liver Cirrhosis on Enhanced MRI
    by: Xinai Liu, et al.
    Published: (2022-07-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs